<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20231213060353N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-02-27</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of the effectiveness of Melissa Officinalis L. nasal drop on the quality of sleep in pregnant women</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the effectiveness of Melissa Officinalis L. nasal drop on the quality of sleep in pregnant women</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-01-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>100</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/74642</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: In this study, all study groups will contain equal sample size, which can be used by limited randomization. The method that is used in this study, will be permuted block randomization . In this method, the size of all blocks will be equal and 10 blocks of 10 will be selected by the "Random software allocation" software, which is capable of generating a random sequence using the permutation block method. The randomization unit in this study will be an individual unit, Blinding description: The method of blinding is double-blind, and the researcher is not aware of the contents of the drops, and only the person's name is entered in the randomization table based on the code that the person has. The oils whose content is unknown and only have A and B labels, are given to patients by one of the pharmacy colleagues.</study_design>
      <phase>3</phase>
      <hc_freetext>Sleep quality of pregnant women in the third trimester.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: pregnant women suffering from sleep disorders referring to the pregnancy clinic of Mahdiyeh Hospital: a prepared and approved sample of Melissa Officinalis will be poured into a standard amount of neutral oil and then a standard amount of sterile water will be added to it. then It will be expousered to indirect heat so the water will completely be evaporated, and finally, the remaining plant will be filtered from the oil so the final product of lemongrass plant oil will be derived from it. The method of using neutral oil (placebo) and lemon balm oil (intervention) is to drip one drop of the respective oil in each nostril twice a day . The medication will be consumed for 8 weeks. The drops will be made by the Faculty of Traditional Medicine of Tehran University of Medical Sciences. Intervention 2: Control group: pregnant women suffering from sleep disorders referring to pregnancy clinic of Mahdiyeh Hospital who receive neutral oil. neutral oil is an oil that has no effect in the treatment of sleep disorder and its preparation is industrial and contains liquid Paraffin.The drops will be made by the Faculty of Traditional Medicine of Tehran University of Medical Sciences.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is Privacy of participants</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zahra Rastegari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Fatemeh (P.B.U.H) School of nursing and midwifery, Namazi hospital, Namazi square, Shiraz, Iran</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7193613119</zip>
        <telephone>+98 71 3647 4254</telephone>
        <email>rategariz@sums.ac0ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zahra Rastegari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Fatemeh (P.B.U.H) School of nursing and midwifery, Namazi hospital, Namazi square, Shiraz, Iran</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7193613119</zip>
        <telephone>+98 71 3647 4254</telephone>
        <email>rategariz@sums.ac0ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Willingness to participate in the study
Gestational age of 28-34 weeks after obtaining informed consent
Mother's first pregnancy (mother's nulligravidity)
Suffering from mild and moderate sleep disorder by self-report and according to the Pittsburgh Questionnaire
Ability to answer questionnaire questions
Not using complementary medicine during the previous three months
No dependence or addiction to alcohol, drugs, tobacco and medicines
Not having family problems
No history of any respiratory allergy
Not having a history of allergy to Lemon balm or cross-reaction with the mint family as self-reported</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>45 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Taking drugs that affect the sleep-wake cycle
The presence of any problems in the pregnancy process
Suffering from depression or anxiety (self-reported and the need to take medication)
Suffering from any psychological factor interfering with sleep disorders
Suffering from kidney diseases, heart failure, respiratory disorders and sleep-wake cycle diseases such as espiratory apnea and restless leg syndrome.
Showing any allergic reaction to lemon balm oil
continuous consumption (twice or more per week) of Lemongrass tea or extract during the last month
having problems related to airway and nasal obstruction and Sinusitis</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: pregnant women suffering from sleep disorders referring to the pregnancy clinic of Mahdiyeh Hospital: a prepared and approved sample of Melissa Officinalis will be poured into a standard amount of neutral oil and then a standard amount of sterile water will be added to it. then It will be expousered to indirect heat so the water will completely be evaporated, and finally, the remaining plant will be filtered from the oil so the final product of lemongrass plant oil will be derived from it. The method of using neutral oil (placebo) and lemon balm oil (intervention) is to drip one drop of the respective oil in each nostril twice a day . The medication will be consumed for 8 weeks. The drops will be made by the Faculty of Traditional Medicine of Tehran University of Medical Sciences.</i_keyword>
      <i_keyword>Control group: pregnant women suffering from sleep disorders referring to pregnancy clinic of Mahdiyeh Hospital who receive neutral oil. neutral oil is an oil that has no effect in the treatment of sleep disorder and its preparation is industrial and contains liquid Paraffin.The drops will be made by the Faculty of Traditional Medicine of Tehran University of Medical Sciences.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Percentage of pregnant women who have sleep disorders. Timepoint: Registration of Pittsburgh sleep quality questionnaire at the beginning of the study (before the start of the intervention) and 4 and 8 weeks after starting the use of Lemon balm oil drops. Method of measurement: Pittsburgh sleep quality questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Sleep quality score. Timepoint: At the beginning of the study and 4 and 8 weeks after the beginning of Lemon balm oil drops. Method of measurement: Pittsburgh Sleep Quality Questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-09-09</approval_date>
        <contact_name>Ethics committee of Shiraz University of Medical Sciences</contact_name>
        <contact_address>No. 39, Joahari Naad Ave., Shir Mohamadi St. , Nazi Abad, Tehran, Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
